--- title: The evidence is in | GammaTile image: https://roads.gammatile.com/hubfs/GT_Website_OpenGraphImage_ROADS_300DPI-fnl.png --- [Skip to main content](https://roads.gammatile.com/evidence#main-content) ![GammaTile](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/gammatile-logo-reverse.svg) # The evidence is in. The results from the ROADS Randomized Controlled Trial are now published in the *Journal of Clinical Oncology*. [Read the Manuscript (opens in a new tab)](https://ascopubs.org/doi/10.1200/JCO-26-01894) ## The evidence is just the beginning. See how GammaTile can enhance your practice. - ![](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/icons/program.svg) ### Build a Program Whether you’re considering GammaTile® or already using it, connect with your GammaTile Representative to explore what the ROADS data could mean for your practice. [Contact a Representative (opens in a new tab)](https://roads.gammatile.com/contact-a-representative?hsLang=en) - ![](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/icons/share.svg) ### Share the Evidence Send the published ROADS manuscript to a colleague or members of your multidisciplinary team. Share the Manuscript - ![](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/icons/chat.svg) ### Talk with a Peer Talk with a peer who uses GammaTile and hear firsthand how they’ve incorporated it into their practice. [Connect with a Provider (opens in a new tab)](https://roads.gammatile.com/connect-with-a-provider?hsLang=en) [![](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/icons/monitor-play.svg) Go beyond the publication. Explore ROADS webinars below.](https://roads.gammatile.com/evidence#webinars) ## See who’s currently offering GammaTile in your region Explore our national network of centers currently using GammaTile to treat patients with operable brain tumors. ## ROADS: Expert Perspectives Hear from Experts as they explore the published **ROADS findings**, **key takeaways**, and **implications for clinical practice**. ![](https://roads.gammatile.com/hs-fs/hubfs/raw_assets/public/roads-theme/images/videos/thumb-sloan.jpg?width=1600&height=900&name=thumb-sloan.jpg) ### A Radiation Oncologist’s Evolution with GammaTile, Shaped by the New ROADS Data Lindsey Sloan, MD, PhD Associate Professor, Department of Radiation Oncology University of Minnesota Dr. Sloan shares how her perspective on GammaTile has evolved and what the new ROADS data presented at ASCO 2026 confirms for her. Hear what stood out in the results, how it’s shaping her treatment decisions, and what she’d tell colleagues considering GammaTile. Length: ~5 minutes Watch Now: A Radiation Oncologist’s Evolution with GammaTile, Shaped by the New ROADS Data ![](https://roads.gammatile.com/hs-fs/hubfs/raw_assets/public/roads-theme/images/videos/thumb-shepard.jpg?width=1600&height=900&name=thumb-shepard.jpg) ### A Neurosurgeon’s View: Dr. Shepard on GammaTile and the New ROADS Data Matthew J. Shepard, MD Assistant Professor of Neurosurgery, Drexel University School of Medicine, Allegheny Health Network Neuroscience Institute Allegheny Health Dr. Shepard shares his perspective on the new ROADS data presented at ASCO 2026 and where GammaTile fits into upfront cases. Hear which patients he considers strong candidates, how he collaborates with radiation oncology, and what he’d tell fellow neurosurgeons considering GammaTile for their own upfront cases. Length: ~17 minutes Watch Now: A Neurosurgeon’s View: Dr. Shepard on GammaTile and the New ROADS Data ![](https://roads.gammatile.com/hs-fs/hubfs/raw_assets/public/roads-theme/images/videos/thumb-panel.jpg?width=1600&height=900&name=thumb-panel.jpg) ### Four Physicians, Two Specialties, One Conversation About the New ROADS Data K. Stuart Lee, MD, FACS Simon Hanft, MD, FAANS M. Sean Peach, MD, PhD Rohil Shekher, MD Drs. Lee, Hanft, Peach, and Shekher bring neurosurgery and radiation oncology together for a candid discussion of the new ROADS data. Hear what stood out in the findings, how the data addresses common misconceptions about GammaTile, and how they collaborate and think about GammaTile for newly diagnosed patients. Length: ~55 minutes Watch Now: Four Physicians, Two Specialties, One Conversation About the New ROADS Data ![](https://roads.gammatile.com/hs-fs/hubfs/talking-to-patients.jpg?width=1280&height=720&name=talking-to-patients.jpg) ### Talking to Patients About GammaTile and ROADS: A Neurosurgery and Radiation Oncology Perspective K. Stuart Lee, MD, FACS Simon Hanft, MD, FAANS M. Sean Peach, MD, PhD Rohil Shekher, MD When a patient hears they have a brain metastasis, the treatment conversation can feel overwhelming. In this discussion, two neurosurgeons and two radiation oncologists sit down to share how they approach that conversation in clinic. Dr. Stuart Lee, Dr. Simon Hanft, Dr. M. Sean Peach, and Dr. Rohil Shekher walk through how they introduce GammaTile as an option to newly diagnosed patients and how they explain the ROADS data in a way patients can follow. Length: 9:36 Watch Now: Talking to Patients About GammaTile and ROADS: A Neurosurgery and Radiation Oncology Perspective Share it. Discuss it. Explore what it could mean for your practice. [Contact a Representative (opens in a new tab)](https://roads.gammatile.com/contact-a-representative?hsLang=en) MKT-674-01 ## Important Safety Information GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). GammaTile should not be used for patients with a known history of hypersensitivity to bovine-derived materials. More information on indications, contraindications, warnings, and instructions for use can be found in the GammaTile Instructions for Use. ![GT Medical Technologies](https://roads.gammatile.com/hubfs/raw_assets/public/roads-theme/images/gt-medical-logo.svg) GT Medical Technologies is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. [LEARN MORE](https://gammatile.com/hcp/about-gt-medical-technologies/). © 2026 GT Medical Technologies, Inc. All rights reserved. GammaTile is a registered trademark of GT Medical Technologies, Inc.